Warning: You're using a guest account.
Unless you register as a full user all information associated with this session will be deleted within 24 hours.
QTL for morphine antinociception on Chr10 at D10Mit51 (19.52 Mbp , Build 37)
Description:
morphine antinociception spans 0.00 - 44.52 Mbp (NCBI Build 37) on Chr10. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Bergeson SE, Helms ML, O\'Toole LA, Jarvis MW, Hain HS, Mogil JS, Belknap JK
QTL for morphine preference on Chr10 at D10MIT282 (24.33 Mbp , Build 37)
Description:
morphine preference spans 0.00 - 49.33 Mbp (NCBI Build 37) on Chr10. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Berrettini WH, Ferraro TN, Alexander RC, Buchberg AM, Vogel WH
QTL associated with anti-erythrocyte autoantibody modifier 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (82117849)
Authors:
Ochiai K, Ozaki S, Tanino A, Watanabe S, Ueno T, Mitsui K, Toei J, Inada Y, Hirose S, Shirai T, Nishimura H
QTL associated with age related thymic involution 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (66329535)
Authors:
Hsu HC, Zhang HG, Li L, Yi N, Yang PA, Wu Q, Zhou J, Sun S, Xu X, Yang X, Lu L, Van Zant G, Williams RW, Allison DB, Mountz JD
QTL associated with arthropathy in MRL and DBA/1 mice 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (72139307)
Authors:
Oishi H, Miyazaki T, Mizuki S, Kamogawa J, Lu LM, Tsubaki T, Arita N, Ono M, Yamamoto H, Nose M
QTL associated with B.burgdorferi-associated arthritis 18. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (65964981)
Authors:
Roper RJ, Weis JJ, McCracken BA, Green CB, Ma Y, Weber KS, Fairbairn D, Butterfield RJ, Potter MR, Zachary JF, Doerge RW, Teuscher C
QTL associated with cystic fibrosis intestinal distress. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (46564113)
QTL associated with collagen induced arthritis QTL 8. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (74337186)
QTL associated with directional asymmetry QTL 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (51337110)
QTL associated with directional asymmetry QTL 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (51337110)
QTL associated with experimental allergic encephalomyelitis susceptibility 17. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (67718408)
QTL associated with hepatocarcinogen resistance 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (66475191)
QTL associated with juvenile cystic kidney modifier 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (66475156)
QTL associated with "lupus in MRL and B6 F2 cross, QTL 4". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (64906889)
Authors:
Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH